IQVIA HOLDINGS INC. Deferred Foreign Income Tax Expense (Benefit)
IQVIA HOLDINGS INC. (IQV) reported Deferred Foreign Income Tax Expense (Benefit) of -$48.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-02-17
- IQVIA HOLDINGS INC. deferred foreign income tax expense (benefit) for fiscal 2025 was -$48.00M.
- IQVIA HOLDINGS INC. deferred foreign income tax expense (benefit) for fiscal 2024 was -$13.00M.
- IQVIA HOLDINGS INC. deferred foreign income tax expense (benefit) for fiscal 2023 was -$33.00M.
- IQVIA HOLDINGS INC. deferred foreign income tax expense (benefit) for fiscal 2022 was -$28.00M.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month | Deferred Foreign Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$48.00M 10-K · filed 2026-02-17 | |
| 2024-12-31 | -$13.00M 10-K · filed 2026-02-17 | |
| 2023-12-31 | -$33.00M 10-K · filed 2026-02-17 | |
| 2022-12-31 | -$28.00M 10-K · filed 2025-02-13 | |
| 2021-12-31 | -$40.00M 10-K · filed 2024-02-15 | |
| 2020-12-31 | -$11.00M 10-K · filed 2023-02-15 | |
| 2019-12-31 | -$34.00M 10-K · filed 2022-02-16 | |
| 2018-12-31 | -$21.00M 10-K · filed 2021-02-12 | |
| 2017-12-31 | -$44.00M 10-K · filed 2020-02-18 | -$41.00M 10-K · filed 2018-02-16 |
| 2016-12-31 | -$19.00M 10-K · filed 2019-02-19 | -$14.00M 10-K · filed 2017-02-16 |
| 2015-12-31 | -$6.00M 10-K · filed 2018-02-16 | -$5.77M 10-K · filed 2016-02-11 |
| 2014-12-31 | -$3.00M 10-K · filed 2017-02-16 | -$3.43M 10-K · filed 2015-02-12 |
| 2013-12-31 | -$6.24M 10-K · filed 2016-02-11 | |
| 2012-12-31 | -$991.00K 10-K · filed 2015-02-12 | |
| 2011-12-31 | -$22.48M 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |